Norepinephrine Drip Administration Protocol

Preparation and Dosing

Norepinephrine should be administered as a continuous infusion starting at 0.5 mg/h and titrated up to 3 mg/h based on patient response, with the goal of increasing mean arterial pressure by 10 mmHg or achieving urine output >50 mL/h, as recommended by the American College of Gastroenterology 1
Standard adult concentration: Add 4 mg of norepinephrine to 250 mL of D5W to yield a concentration of 16 μg/mL, according to the American Academy of Allergy, Asthma, and Immunology 2
Alternative concentration for anaphylaxis: Add 1 mg of norepinephrine to 100 mL of saline to create a 1:100,000 solution, administered at 30-100 mL/h, as suggested by the American Academy of Allergy, Asthma, and Immunology 2

Administration Route

Central venous access is preferred for administration of norepinephrine, as recommended by the American College of Gastroenterology 1
If central access is unavailable or delayed, peripheral IV or intraosseous administration can be used temporarily, according to the Society of Critical Care Medicine 3

Monitoring and Titration

Monitor blood pressure and heart rate every 5-15 minutes during initial titration, as recommended by the Society of Critical Care Medicine 3
Titrate dose to achieve target mean arterial pressure or adequate tissue perfusion, as suggested by the American College of Gastroenterology 1
For septic shock, target normalization of capillary refill and age-appropriate heart rate, according to the Society of Critical Care Medicine 4
Increase dose by 0.5 mg/h every 4 hours as needed, to a maximum of 3 mg/h, as recommended by the American College of Gastroenterology 1
Monitor for signs of excessive vasoconstriction, such as cold extremities, decreased urine output, as suggested by the Society of Critical Care Medicine 3

Precautions and Complications

Watch for potential side effects including hypertension, arrhythmias, and tissue ischemia, as recommended by the American College of Gastroenterology 1
Ensure adequate volume resuscitation before and during norepinephrine administration to optimize cardiac output, as suggested by the Society of Critical Care Medicine 4 and the Society of Critical Care Medicine 3

Special Considerations

For anaphylaxis, norepinephrine should only be used in cases not responding to epinephrine injections and volume resuscitation, as recommended by the American Academy of Allergy, Asthma, and Immunology 2
In patients with cirrhosis and hepatorenal syndrome, norepinephrine has shown similar efficacy to terlipressin in improving renal function, according to the American College of Gastroenterology 5 and the American College of Gastroenterology 1

Norepinephrine Administration Guidelines

Precautions and Monitoring

The American Academy of Pediatrics recommends phentolamine (0.1-0.2 mg/kg up to 10 mg diluted in 10 mL of 0.9% sodium chloride) injected intradermally at the extravasation site to counteract dermal vasoconstriction in patients receiving norepinephrine therapy 6, 7

Alternative Dilutions for Specific Situations

For anaphylaxis requiring continuous infusion, an alternative 1:100,000 solution (1 mg in 100 mL saline) can be prepared and administered at an initial rate of 30 to 100 mL/h (5-15 mcg/min), titrated based on clinical response, as recommended by the American Academy of Allergy, Asthma, and Immunology 8, 9
For pediatric patients, the "rule of 6" can be used - 0.6 × body weight (kg) = number of milligrams diluted to total 100 mL of saline; then 1 mL/h delivers 0.1 mcg/kg/min, according to the American Academy of Allergy, Asthma, and Immunology 8, 10

Pediatric Considerations

The American Academy of Pediatrics recommends pediatric dosing of norepinephrine typically ranging from 0.1-1.0 mcg/kg per minute, starting at the lowest dose and titrating to desired clinical effect 6, 11
Doses as high as 5 mcg/kg per minute are sometimes necessary in children, as stated by the American Academy of Pediatrics 6, 11

Norepinephrine Administration Guidelines

Administration Route and Monitoring

Central venous access is preferred for administration of norepinephrine to minimize risk of extravasation, and if central access is unavailable or delayed, peripheral IV administration can be used temporarily with strict adherence to protocols including proper site selection, according to the American Heart Association 12
Norepinephrine and other catecholamines can produce tissue necrosis if extravasation occurs, and if extravasation develops, infiltrate 5-10 mg of phentolamine diluted in 10-15 mL of saline into the site of extravasation as soon as possible to prevent tissue death and sloughing, as recommended by the American Heart Association 12
Adrenergic drugs should not be mixed with sodium bicarbonate or other alkaline solutions in the IV line, as there is evidence they are inactivated in alkaline solutions, according to the American Heart Association 12

Special Considerations

For specific clinical scenarios such as priapism treatment, phenylephrine is diluted with normal saline, but this is a different medication with different properties, as noted by the American Urological Association 13

Norepinephrine Administration Guidelines

Critical Pre-Administration Requirements

Address hypovolemia first before starting norepinephrine by giving fluid boluses to optimize cardiac output, as vasoconstriction in hypovolemic patients causes severe organ hypoperfusion despite "normal" blood pressure, as recommended by the Intensive Care Medicine guidelines 14

Monitoring Protocol

Monitor blood pressure and heart rate every 5-15 minutes during initial titration, as recommended by the Intensive Care Medicine guidelines 14

Special Clinical Scenarios

For beta-blocker toxicity, norepinephrine is more effective than dopamine for hypotension, according to the American Heart Association, as published in Circulation 15
For cardiac arrest, high-dose IV norepinephrine may be used for refractory arrest, as recommended by the Journal of Allergy and Clinical Immunology 16

Peripheral Administration of Norepinephrine

Dosing and Administration

The American Heart Association recommends starting with a dose of 0.1-0.5 mcg/kg/min (7-35 mcg/min in a 70 kg adult) and titrating every 4 hours as needed, up to a maximum of 3 mg/h, for peripheral administration of norepinephrine 17, 18

Management of Extravasation

If extravasation occurs, the American Academy of Pediatrics recommends infiltrating phentolamine 5-10 mg diluted in 10-15 mL of saline solution intradermally at the site, with a pediatric dose of 0.1-0.2 mg/kg up to 10 mg 17, 19, 20

Management of Septic Shock with Norepinephrine and Fluid Resuscitation

Initial Resuscitation

Initial resuscitation requires crystalloid fluid boluses (minimum 30 mL/kg) BEFORE or concurrent with vasopressor initiation, as recommended by the Surviving Sepsis Campaign guidelines (strong recommendation, moderate quality evidence) 21, 22
Norepinephrine is the first-choice vasopressor for septic shock (strong recommendation, moderate quality evidence) 21, 22
Crystalloids (including normal saline or balanced crystalloids) are recommended for initial resuscitation 21, 22

Target Blood Pressure

Target mean arterial pressure (MAP) of 65 mmHg for septic shock, as recommended by the Surviving Sepsis Campaign guidelines 21, 22

Norepinephrine Dosing Guidelines

Dosing Ranges by Indication

The typical range for norepinephrine dosing in septic shock is 0.1-2 mcg/kg/min, as recommended by the American Heart Association, based on evidence from Circulation 23

Norepinephrine Drip Order Guidelines

Target Blood Pressure

The target mean arterial pressure (MAP) of 65 mmHg for septic shock is recommended by the Society of Critical Care Medicine 24, 25

Monitoring and Administration

The American College of Critical Care Medicine suggests placing an arterial catheter as soon as practical for continuous monitoring 24, 25
Norepinephrine is the first-choice vasopressor over dopamine, epinephrine, or phenylephrine for initial management, as recommended by the European Society of Intensive Care Medicine 24, 25

Norepinephrine Dosing and Administration

Concentration Preparation

An alternative concentration of 10 mcg/mL can be prepared by adding 1 mg of norepinephrine to 100 mL of saline, which is sometimes used in anaphylaxis scenarios, as recommended by the Journal of Allergy and Clinical Immunology 26, 27

Pediatric Conversions

Standard pediatric dosing ranges from 0.1-1.0 mcg/kg/min, starting at the lowest dose and titrating to effect, according to Pediatrics 28
The "Rule of 6" provides a simplified approach for pediatric patients: multiply 0.6 × body weight (kg) to get the number of milligrams, then dilute to 100 mL of saline, as described in the Journal of Allergy and Clinical Immunology 27

Critical Considerations

Extravasation risk can be mitigated by using central venous access when possible, as norepinephrine can cause severe tissue necrosis with extravasation, and infiltrating phentolamine 5-10 mg diluted in 10-15 mL saline at the site immediately if extravasation occurs, as recommended by Pediatrics 28
Inadequate volume resuscitation can be avoided by addressing hypovolemia with crystalloid boluses (minimum 30 mL/kg) before starting norepinephrine, to prevent severe organ hypoperfusion 28

Norepinefrina Administration Guidelines

Initial Dosing and Preparation

The American Heart Association recommends initiating norepinefrine at 0.1-0.5 mcg/kg/min (7-35 mcg/min in a 70 kg adult) via continuous intravenous infusion, titrating to achieve a mean arterial pressure (MAP) goal of 65-100 mmHg 29
Administer norepinefrine preferably through a central venous line to prevent tissue necrosis from extravasation 29

Precautions and Complications Management

If extravasation occurs, infiltrate 5-10 mg of phentolamine diluted in 10-15 mL of saline solution at the site as soon as possible to prevent tissue death 29
Use with caution in patients with ischemic heart disease as it may increase myocardial oxygen demand 29
Do not mix with sodium bicarbonate or other alkaline solutions in the IV line, as adrenergic agents are inactivated in alkaline solutions 29

Norepinephrine Dosing for Hypotension

Target Blood Pressure

The target mean arterial pressure (MAP) should be ≥65 mmHg to preserve tissue perfusion in septic shock, according to the Critical Care Medicine guideline 30
Patients with chronic hypertension or atherosclerosis may require higher MAP targets, while younger normotensive patients may tolerate lower pressures, as recommended by the Critical Care Medicine guideline 30
Titration of norepinephrine should be guided by both MAP and markers of tissue perfusion, including lactate clearance, urine output, mental status, and capillary refill, as suggested by the Critical Care Medicine guideline 30

Combination Therapy

When norepinephrine reaches 0.25 mcg/kg/min and hypotension persists, vasopressin (0.03-0.04 units/min) should be added as second-line therapy rather than continuing to escalate norepinephrine alone, according to the Critical Care Medicine guideline 30

Fluid Resuscitation Requirements

A minimum 30 mL/kg crystalloid bolus should be administered before or concurrent with norepinephrine initiation, as recommended by the Critical Care Medicine guideline 30
In severe hypotension (systolic <70 mmHg), norepinephrine should be started as an emergency measure while fluid resuscitation continues, rather than waiting for complete volume repletion, according to the Critical Care Medicine guideline 30

Monitoring Requirements

Tissue perfusion markers, such as lactate, mental status, urine output, and capillary refill, should be assessed, as recommended by the Critical Care Medicine guideline 30

Norepinephrine Dilution and Administration Guidelines

Pediatric Dosing and Administration

The American Academy of Pediatrics recommends a starting dose of 0.1 mcg/kg/min, titrated to desired clinical effect, with a typical range of 0.1-1.0 mcg/kg/min, and maximum doses up to 5 mcg/kg/min may be necessary in some children 31
For pediatric patients, the phentolamine dose for extravasation management is 0.1-0.2 mg/kg up to 10 mg diluted in 10 mL of 0.9% sodium chloride 31

Sepsis Management with Norepinephrine

Fluid Resuscitation Recommendations

The Surviving Sepsis Campaign strongly recommends against using hydroxyethyl starch (HES) for fluid resuscitation in septic shock, and norepinephrine should be used with crystalloid solutions instead of colloids 32
Crystalloid solutions are the first choice for fluid resuscitation in septic shock when using norepinephrine, with an initial dose of at least 30 mL/kg before or simultaneously with norepinephrine 32
Hydroxyethyl starch (HES) is strongly discouraged in septic shock due to increased mortality (51% vs 43%, p=0.03 in the 6S study) 32
Gelatin and dextran are not recommended for use 33

Norepinephrine Administration

Norepinephrine should be administered through a central venous catheter to avoid tissue necrosis in case of extravasation 32
The target mean arterial pressure (MAP) is ≥65 mmHg 32
Vasopressin 0.03 units/min can be added when norepinephrine alone does not achieve the target MAP 32
Epinephrine can be added as a second agent if needed 32
Dopamine should not be used except in specific cases (absolute bradycardia, low risk of arrhythmias) 32

Pitfalls to Avoid

Hydroxyethyl starch (HES) should never be used with norepinephrine due to increased mortality and renal injury (CHEST and 6S studies) 32
Excessive fluid resuscitation should be avoided, using a conservative strategy instead of a liberal one 33
Albumin should only be considered when large amounts of crystalloids are needed 32
Dopamine should not be combined with epinephrine 34
Phenylephrine should not be used as a first-line agent, only in specific cases 32
Low-dose dopamine should not be used to protect the kidneys, as it has no benefit 32

Norepinephrine Initiation in Hypotensive Patients

Critical Pre-Administration Requirements

The American College of Critical Care Medicine recommends starting norepinephrine at 0.5 mg/h (approximately 8-12 mcg/min or 0.1-0.5 mcg/kg/min) via continuous IV infusion, preferably through central venous access, while simultaneously ensuring adequate fluid resuscitation with at least 30 mL/kg crystalloid bolus 35
Administer a minimum 30 mL/kg crystalloid bolus before or concurrent with norepinephrine initiation, as recommended by the Critical Care Medicine society 35

Administration Route

Central venous access is strongly preferred to minimize extravasation risk, according to the Critical Care Medicine guidelines 35
The Critical Care Medicine society recommends placing an arterial catheter as soon as practical for continuous blood pressure monitoring 35

Target Blood Pressure and Titration

Target mean arterial pressure (MAP) of 65 mmHg, as recommended by the Critical Care Medicine society 35

Escalation Strategy for Refractory Hypotension

The Critical Care Medicine society recommends adding epinephrine 0.1-0.5 mcg/kg/min when norepinephrine reaches 0.25 mcg/kg/min and hypotension persists 35
For persistent hypoperfusion despite adequate vasopressors, add dobutamine up to 20 mcg/kg/min, as recommended by the Critical Care Medicine society 35
Phenylephrine is NOT recommended except in specific circumstances, such as norepinephrine causing serious arrhythmias, according to the Critical Care Medicine guidelines 35

Special Considerations

Norepinephrine is the mandatory first-choice vasopressor in septic shock context, with strong recommendation and moderate quality evidence, as stated by the Critical Care Medicine society 35
The Critical Care Medicine society does not recommend using dopamine as first-line agent, as it is associated with higher mortality and arrhythmias 35
The Critical Care Medicine society also recommends not using low-dose dopamine for renal protection, as it has no benefit and is strongly discouraged 35

Norepinephrine Starting Dose for Hypotension

Initial Dosing Parameters

The American College of Cardiology recommends starting norepinephrine at 0.02 mcg/kg/min, administered as a continuous IV infusion, while ensuring adequate fluid resuscitation with at least 30 mL/kg crystalloid bolus 36
The Surviving Sepsis Campaign guidelines suggest using balanced crystalloids, such as lactated Ringer's or Plasma-Lyte, preferentially over normal saline for fluid resuscitation 36
In pregnant patients with sepsis, the guidelines recommend considering more restrictive initial boluses of 1-2 L due to lower colloid oncotic pressure and higher pulmonary edema risk 36

Administration Route and Monitoring

Central venous access is strongly preferred to minimize extravasation risk and tissue necrosis, according to the Mayo Clinic Proceedings 36

Target Blood Pressure and Titration

The standard goal for septic shock is to target a mean arterial pressure (MAP) of 65 mmHg, as recommended by the Mayo Clinic Proceedings 36

Escalation for Refractory Hypotension

When norepinephrine reaches 0.1-0.25 mcg/kg/min and hypotension persists, the Surviving Sepsis Campaign guidelines support adding vasopressin 0.03-0.04 units/min as second-line therapy 36

Special Populations

In pregnant patients, the guidelines recommend starting norepinephrine at 0.02 mcg/kg/min with a target MAP of 65 mmHg 36
Consider adding vasopressin 0.04 units/min for refractory shock in pregnant patients, with fetal monitoring when appropriate 36

Norepinephrine Dose Calculation and Administration

Introduction to Norepinephrine Administration

The American College of Cardiology recommends initiating norepinephrine at 0.5 mg/h, titrated every 4 hours by 0.5 mg/h increments to a maximum of 3 mg/h, targeting a mean arterial pressure of 65 mmHg 37
The American Heart Association suggests targeting a MAP of 65 mmHg for most patients, but individualizing based on chronic hypertension status and tissue perfusion markers 37, 38

Special Clinical Scenarios

In hepatorenal syndrome, the European Association for the Study of the Liver recommends starting norepinephrine at 0.5 mg/h, increasing every 4 hours by 0.5 mg/h to a maximum of 3 mg/h, with a goal to increase MAP by ≥10 mmHg and/or urine output >50 mL/h for at least 4 hours 37
In septic shock, the Surviving Sepsis Campaign recommends norepinephrine as the first-choice vasopressor, targeting a MAP of 65 mmHg with normalization of capillary refill and age-appropriate heart rate 37

Monitoring and Administration

The American Society of Health-System Pharmacists recommends monitoring blood pressure every 5-15 minutes during initial titration and assessing tissue perfusion: lactate clearance, urine output >50 mL/h for 4 hours, mental status, capillary refill 37
Central venous access is strongly preferred to minimize extravasation risk and tissue necrosis, as recommended by the Infectious Diseases Society of America 37

Norepinephrine Dosing for Blood Pressure Support in Septic Shock

Target Blood Pressure

The American College of Critical Care Medicine recommends a target mean arterial pressure (MAP) of 65 mmHg for most patients with septic shock, with strong recommendation and moderate quality evidence 39

Administration Route and Monitoring

The American College of Critical Care Medicine strongly prefers central venous access to minimize extravasation risk and tissue necrosis, with strong recommendation and moderate quality evidence 39
The American College of Critical Care Medicine suggests placing an arterial catheter as soon as practical for continuous blood pressure monitoring, with weak recommendation and very low quality evidence 39

Escalation Strategy for Refractory Hypotension

The American College of Critical Care Medicine recommends adding vasopressin 0.03 units/min when norepinephrine reaches 0.25 mcg/kg/min and hypotension persists, with weak recommendation and moderate quality evidence 39
The American College of Critical Care Medicine suggests adding epinephrine 0.1-0.5 mcg/kg/min to norepinephrine, with weak recommendation and low quality evidence 39
The American College of Critical Care Medicine advises against increasing vasopressin above 0.03-0.04 units/min, reserving higher doses for salvage therapy only, with strong recommendation and moderate quality evidence 39

Inotropic Support

The American College of Critical Care Medicine recommends adding dobutamine up to 20 mcg/kg/min if persistent hypoperfusion exists despite adequate vasopressors, particularly with myocardial dysfunction, with weak recommendation and low quality evidence 39

Pediatric Dosing

The American Academy of Pediatrics recommends starting norepinephrine at 0.1 mcg/kg/min, titrating to desired clinical effect, with moderate quality evidence 40

Critical Pitfalls to Avoid

The American College of Critical Care Medicine advises against using dopamine as first-line agent, associated with higher mortality and more arrhythmias compared to norepinephrine, with weak recommendation and low quality evidence 39
The American College of Critical Care Medicine strongly discourages using low-dose dopamine for renal protection, with no benefit and high quality evidence 39
The American College of Critical Care Medicine recommends against using phenylephrine as first-line therapy, which may raise blood pressure while worsening tissue perfusion, with strong recommendation and moderate quality evidence 39

Norepinephrine Drip Management in Special Clinical Scenarios

Anaphylaxis and Refractory Hypotension

In cases of anaphylaxis not responding to epinephrine injections and volume resuscitation, norepinephrine infusion can be added at 0.05-0.1 mcg/kg/min for persistent hypotension after 10 minutes despite epinephrine boluses, as recommended by the British Journal of Anaesthesia 41

Management of Noradrenaline Administration via Peripheral Line

Protocol Requirements for Safe Peripheral Administration

The American Academy of Pediatrics recommends infiltrating phentolamine 5-10 mg diluted in 10-15 mL of 0.9% sodium chloride intradermally at the site of extravasation to prevent tissue necrosis, with a pediatric dose of 0.1-0.2 mg/kg up to 10 mg 42
For pediatric patients, the typical range for peripheral noradrenaline administration is 0.1-1.0 μg/kg/min, starting at the lowest dose, with maximum doses up to 2.0 μg/kg/min requiring central access 42
In pediatric patients, doses as high as 5 μg/kg/min may be necessary in exceptional circumstances, mandating central line placement 42

Pediatric Vasopressin Dosing Guidelines

Introduction to Vasopressin Therapy

For pediatric patients with vasodilatory shock, the initial vasopressin dose should be 0.0002-0.0005 units/kg/min, titrated up to a maximum of 0.002 units/kg/min based on hemodynamic response, as recommended by the American College of Critical Care Medicine 43
In the context of septic shock, vasopressin should be used at doses ≤0.04 units/kg/min as an adjunctive agent, with pediatric-specific dosing typically ranging from 0.0002-0.002 units/kg/min 43

Clinical Context and Indications

Vasopressin should be reserved as a rescue therapy for catecholamine-resistant vasodilatory shock, not as a first-line agent, according to the American College of Critical Care Medicine 43
The American College of Critical Care Medicine recommends adding vasopressin when norepinephrine reaches 0.25 mcg/kg/min and hypotension persists, though pediatric dosing follows weight-based ranges 43

Important Adverse Effects and Precautions

Avoid using vasopressin without adequate volume resuscitation, as excessive vasoconstriction in hypovolemic patients can cause severe organ hypoperfusion, as cautioned by the American College of Critical Care Medicine 43

Alternative Considerations

Terlipressin, a long-acting form of vasopressin, has been reported to reverse vasodilatory shock in pediatric patients, though specific dosing recommendations are less well-established, according to the American College of Critical Care Medicine 43

Safety and Efficacy

The safety and efficacy of vasopressin in pediatric septic shock remain uncertain pending results of ongoing randomized controlled trials, as noted by the American College of Critical Care Medicine 43

Norepinephrine Administration via Intraosseous Line

Guideline Support for IO Administration

The Surviving Sepsis Campaign (2020) explicitly states that epinephrine or norepinephrine may be administered through a peripheral vein or intraosseous line if central venous access is not readily accessible, particularly after 40-60 mL/kg of fluid resuscitation in children with septic shock 44
The American Heart Association (2010) confirms that all intravenous medications can be administered intraosseously, including catecholamines, with onset of action and drug levels comparable to venous administration 45

Practical Administration Protocol

Follow each medication with a saline flush to promote entry into the central circulation 45
Use manual pressure or an infusion pump to administer the infusion, as IO access may require additional pressure for adequate flow 45
Transition to central venous access as soon as practical for longer-term administration, though IO can be used safely for the duration needed in emergency situations 45

Critical Considerations

Blood samples can be obtained through IO access for analysis including type and cross-match, though acid-base analysis is inaccurate after sodium bicarbonate administration via the IO cannula 45

Duration and Dose Limitations

Plan for central line placement if norepinephrine will be needed beyond the initial resuscitation period 44

Vasopressor Support in Septic Shock

Inotropic Support

The European Heart Journal recommends starting dobutamine at 2.5 mcg/kg/min, doubling the dose every 15 minutes according to response, with dose titration usually limited by excessive tachycardia, arrhythmias, or ischemia 46
Dobutamine should be added up to 20 mcg/kg/min rather than escalating epinephrine if the patient has evidence of myocardial dysfunction with persistent hypoperfusion despite adequate vasopressors 46

Norepinephrine Administration Guidelines

Primary Indication and Dosing

The World Journal of Emergency Surgery recommends a target mean arterial pressure (MAP) of 65 mmHg for most patients, with norepinephrine as the first-line vasopressor 47
The Critical Care Medicine journal suggests that dopamine should not be used as first-line therapy, as it is associated with higher mortality and more arrhythmias compared to norepinephrine 48
The World Journal of Emergency Surgery also recommends against using low-dose dopamine for "renal protection", as it provides no benefit and is strongly discouraged 47

Special Clinical Scenarios

In septic shock, norepinephrine is the mandatory first-choice vasopressor, with strong recommendation and moderate quality evidence, according to the World Journal of Emergency Surgery 47
In pediatric patients, the Critical Care Medicine journal recommends starting at 0.1 mcg/kg/min, titrating to desired clinical effect, with a typical range of 0.1-1.0 mcg/kg/min 48

Adverse Effects

The Intensive Care Medicine journal notes that norepinephrine may cause a transient increase in serum lactate, which is not clinically relevant 49

Norepinephrine Dosage Calculation for Adults

Special Clinical Scenarios

For patients with anaphylaxis refractory to epinephrine, the British Journal of Anaesthesia recommends using norepinephrine infusion at 0.05-0.1 mcg/kg/min for persistent hypotension after 10 minutes despite epinephrine boluses and volume resuscitation 50

Norepinephrine Use in Septic Shock

Initial Treatment

For septic shock, norepinephrine is the mandatory first-choice vasopressor, preferred over dopamine, epinephrine, or phenylephrine, with a strong recommendation and moderate quality evidence, according to the Intensive Care Medicine guidelines 51
The target mean arterial pressure (MAP) for most patients with septic shock is 65 mmHg, representing the minimum threshold for adequate organ perfusion, based on strong guideline recommendations from Intensive Care Medicine 51

Escalation Strategy

When norepinephrine reaches 0.25 mcg/kg/min and hypotension persists, add vasopressin 0.03-0.04 units/min as second-line therapy, rather than continuing to escalate norepinephrine alone, as recommended by Intensive Care Medicine 51
Alternatively, add epinephrine 0.1-0.5 mcg/kg/min if vasopressin is unavailable, according to Intensive Care Medicine guidelines 51
For persistent hypoperfusion despite adequate vasopressors, add dobutamine up to 20 mcg/kg/min if there is evidence of myocardial dysfunction, as recommended by Intensive Care Medicine 51
Consider hydrocortisone 50 mg IV every 6 hours (or 200 mg continuous infusion) for refractory shock requiring high-dose vasopressors, according to Intensive Care Medicine 51

Avoiding Critical Pitfalls

Never use dopamine as first-line therapy, as it is associated with higher mortality and more arrhythmias compared to norepinephrine, according to Intensive Care Medicine guidelines 51

Immediate Management of Norepinephrine Extravasation

Infusion Continuation

The norepinephrine infusion should be stopped immediately, but the existing IV line must be left in place to preserve access to the extravasation site. 52

Catheter Handling

The peripheral IV catheter should not be removed before administering phentolamine, because the catheter serves as a landmark for precise intradermal infiltration of the antidote. 52

Post‑Treatment Observation

Patients should remain under observation for at least 24 hours after phentolamine treatment; discharge should be delayed until it is confirmed that no further tissue injury is developing. 52

Administration of Vasopressors and Blood Products via Separate IV Lines

Peripheral Access Recommendations

When central venous access is not yet available during early resuscitation, clinicians should place two distinct peripheral intravenous lines—one dedicated to the vasopressor infusion and a second dedicated to the blood product infusion—to avoid mixing incompatible fluids and to allow independent titration of each therapy. 53
If a vasopressor is delivered through a peripheral line, it should be diluted in a dextrose‑containing solution and run alongside a second carrier fluid that provides a flow rate sufficient to deliver the drug rapidly to the central circulation. 53
For patients with low hemoglobin (e.g., <10 g/dL), blood transfusion must be administered through a dedicated IV port separate from the vasopressor line to maintain dosing precision and prevent drug inactivation. 53

Central Access Recommendations

Multi‑lumen central venous catheters (e.g., triple‑ or quad‑lumen) are preferred, assigning separate lumens for vasopressor infusion, blood product administration, and other medications, thereby eliminating any risk of incompatibility. [no citation – omitted]
If central access is delayed, the same principle of separate peripheral lines or a peripheral line plus intraosseous access should be applied until a dedicated central lumen can be established. 53

Compatibility and Incompatibility

The American Heart Association warns that catecholamine vasopressors (epinephrine, norepinephrine) must not be mixed with alkaline solutions (e.g., sodium bicarbonate) because alkalinity inactivates the drugs; this is a Class I recommendation in the AHA guidelines. 54
Mixing adrenergic agents with any incompatible solution in the same IV line is expressly prohibited, reinforcing the need for separate administration routes. 54

Pediatric Considerations

In pediatric septic shock, after an initial large‑volume crystalloid bolus (≈40–60 mL/kg), epinephrine or norepinephrine may be given via a peripheral vein or intraosseous line only if central access is unavailable, but blood products must still be delivered through a different line. 53
For children with low hemoglobin, red blood cell transfusion should be performed through a separate IV line distinct from any vasopressor infusion. 53

Guideline Recommendations for Norepinephrine Use in Adult Circulatory Shock

Fluid Resuscitation Prior to Vasopressor Initiation

Administer a minimum crystalloid bolus of 30 mL per kilogram of body weight before or concurrently with the start of norepinephrine to prevent severe organ hypoperfusion caused by vasoconstriction in hypovolemic patients. [Intensive Care Medicine guideline] [55]

Vascular Access for Norepinephrine Infusion

Central venous access is strongly preferred for norepinephrine infusion to minimise the risk of extravasation and subsequent tissue necrosis. [Intensive Care Medicine guideline] [55]
If central access is unavailable or delayed, temporary peripheral intravenous or intra‑osseous administration may be used, provided strict monitoring is maintained. [Intensive Care Medicine guideline] [55]

Initial Dosing Parameters

Begin norepinephrine at 0.5 mg per hour (approximately 8–12 µg/min or 0.1–0.5 µg/kg/min) via continuous intravenous infusion. [Intensive Care Medicine guideline] [55]

Hemodynamic Target

Aim for a mean arterial pressure (MAP) of 65 mmHg in most patients with circulatory shock; adjust upward for chronic hypertensive patients or downward for younger normotensive individuals as clinically appropriate. [Intensive Care Medicine guideline] [55]

Escalation Strategy for Refractory Hypotension

When norepinephrine dosing reaches 0.25 µg/kg/min and hypotension persists, add vasopressin at 0.03–0.04 units/min as a second‑line agent rather than further escalating norepinephrine alone. [Intensive Care Medicine guideline] [55]
If tissue hypoperfusion continues despite adequate vasopressor support and there is evidence of myocardial dysfunction, add dobutamine up to 20 µg/kg/min to improve cardiac output. [Intensive Care Medicine guideline] [55]
For refractory shock requiring high‑dose vasopressors, consider hydrocortisone 200 mg per day (administered as continuous infusion or intermittent doses) as an adjunctive therapy. [Intensive Care Medicine guideline] [55]

Norepinephrine Dosing in Septic Shock – Evidence‑Based Recommendations

1. Pre‑Administration Fluid Resuscitation

Administer a minimum of 30 mL/kg of balanced crystalloid before starting norepinephrine to prevent severe organ hypoperfusion that can occur if vasoconstriction is applied to a hypovolemic patient. Strong recommendation; moderate‑quality evidence 56

2. Vascular Access

Central venous catheter is strongly preferred for norepinephrine infusion to minimize the risk of extravasation and tissue necrosis. Peripheral or intra‑osseous routes may be used only as a temporary bridge when central access is unavailable. Strong recommendation 56

3. Hemodynamic Targets

Aim for a mean arterial pressure (MAP) of 65 mmHg in adult patients with septic shock as the minimum threshold for adequate organ perfusion. Strong recommendation; moderate‑quality evidence [56][57]
Support MAP targets with serial tissue‑perfusion markers (e.g., lactate clearance, urine output > 50 mL/h, mental status, capillary refill, skin temperature) to confirm effective resuscitation. Strong recommendation [56][57]

4. Escalation Strategy for Refractory Hypotension

If norepinephrine dose reaches 0.25 µg/kg/min and hypotension persists despite adequate fluid resuscitation, add vasopressin 0.03–0.04 units/min as a second‑line agent. This strategy is supported by moderate‑quality evidence showing reduced norepinephrine requirements. 57
For persistent hypoperfusion with evidence of myocardial dysfunction despite adequate vasopressor support, add dobutamine up to 20 µg/kg/min to improve cardiac output. Moderate‑quality evidence 57

5. Contraindicated or Non‑First‑Line Agents

Dopamine should not be used as first‑line therapy in septic shock because it is associated with higher mortality and a greater incidence of arrhythmias compared with norepinephrine. It may be considered only in highly selected patients with absolute bradycardia and low arrhythmia risk. Strong recommendation; moderate‑quality evidence 57

6. Overall Evidence Summary

Norepinephrine is the first‑choice vasopressor for septic shock, carrying a strong recommendation with moderate‑quality evidence across multiple international guidelines. Strong recommendation; moderate‑quality evidence [56][57]